KF

Krilogy Financial Portfolio holdings

AUM $1.74B
1-Year Return 13.85%
This Quarter Return
+4.7%
1 Year Return
+13.85%
3 Year Return
+49.19%
5 Year Return
+67.98%
10 Year Return
+132.4%
AUM
$322M
AUM Growth
+$0
Cap. Flow
-$682K
Cap. Flow %
-0.21%
Top 10 Hldgs %
53.81%
Holding
738
New
Increased
2
Reduced
5
Closed

Top Buys

1
MNKD icon
MannKind Corp
MNKD
$800

Sector Composition

1 Technology 2.8%
2 Financials 2.41%
3 Industrials 2.31%
4 Healthcare 2.28%
5 Communication Services 1.61%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INSM icon
626
Insmed
INSM
$30.7B
$3K ﹤0.01%
200
OUSA icon
627
ALPS O'Shares US Quality Dividend ETF
OUSA
$828M
$3K ﹤0.01%
100
QSR icon
628
Restaurant Brands International
QSR
$20.7B
$3K ﹤0.01%
65
RSPG icon
629
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$421M
$3K ﹤0.01%
46
SVC
630
Service Properties Trust
SVC
$481M
$3K ﹤0.01%
100
TAP icon
631
Molson Coors Class B
TAP
$9.96B
$3K ﹤0.01%
28
TLPH icon
632
Talphera
TLPH
$11.3M
$3K ﹤0.01%
65
TTNP icon
633
Titan Pharmaceuticals
TTNP
$5.63M
0
-$3K
VAC icon
634
Marriott Vacations Worldwide
VAC
$2.73B
$3K ﹤0.01%
35
VNDA icon
635
Vanda Pharmaceuticals
VNDA
$272M
$3K ﹤0.01%
200
STML
636
DELISTED
Stemline Therapeutics, Inc.
STML
$3K ﹤0.01%
300
CBI
637
DELISTED
Chicago Bridge & Iron Nv
CBI
$3K ﹤0.01%
100
SCMP
638
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$3K ﹤0.01%
200
TEL icon
639
TE Connectivity
TEL
$61.7B
$2K ﹤0.01%
32
HYLD
640
DELISTED
High Yield ETF
HYLD
$2K ﹤0.01%
53
SPPI
641
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2K ﹤0.01%
500
CHK
642
DELISTED
Chesapeake Energy Corporation
CHK
$2K ﹤0.01%
1
ACHN
643
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$2K ﹤0.01%
600
CVRR
644
DELISTED
CVR Refining, LP
CVRR
$2K ﹤0.01%
200
POT
645
DELISTED
Potash Corp Of Saskatchewan
POT
$2K ﹤0.01%
100
ZGNX
646
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
200
ASIX icon
647
AdvanSix
ASIX
$569M
$2K ﹤0.01%
69
CDE icon
648
Coeur Mining
CDE
$9.43B
$2K ﹤0.01%
200
CLDX icon
649
Celldex Therapeutics
CLDX
$1.52B
$2K ﹤0.01%
40
COLL icon
650
Collegium Pharmaceutical
COLL
$1.21B
$2K ﹤0.01%
100